chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Localized burning, redness, swelling, warmth. General malaise 1-2 days after vaccine administration. Marble size lump at injection site. 7 days post vaccine-lump, bruising red, swelling.
shingles outbreak; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (shingles outbreak) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination.     No medical history was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced HERPES ZOSTER (shingles outbreak). On 09-Mar-2021, HERPES ZOSTER (shingles outbreak) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. Patient took some antiviral medication to help with shingles outbreak. It resolved on 09-Mar-2021 but she still has scabs from the outbreak.   This case was linked to MOD-2021-046619 (Patient Link).
Severe tinnitus; Migraine; Body aches; Nausea; Diarrhea; Fever; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 12Feb2021 at 08:00, (at the age of 59- years-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis and neuropathy. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had a history of allergy to lidocaine, Phenergan and trazadone. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and hormonal replacement therapy NORCO, both for unknown indication. The patient had experienced nausea, diarrhoea, severe tinnitus, fever, body aches and migraine on 13Feb2021 at 16:00. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nausea, diarrhoea, tinnitus, fever, pain and migraine was not resolved at the time of this report.  No further information expected. Information on lot/batch number has been requested.
Full body hives six days after vaccination; A spontaneous report was received from a 41-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced full body hives six days after vaccination.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot: 025J20-2A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On unknown date, 6 days later the patient developed full body hives six days after vaccination. Treatment provided included diphenhydramine hydrochloride and prednisone.    Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, full body hives six days after vaccination, was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
felt like there was a lot of pressure on her chest/heaviness in chest; congestion; Lip swelling; Upset stomach; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 22Mar2021 13:00 (Lot Number: ER2613) as SINGLE DOSE for COVID-19 immunisation. Medical history included thyroid from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (TIROSINT) taken for thyroid, start and stop date were not reported. The patient previously took thiomersal and experienced allergy to thiomersal. On 22Mar2021, the patient had some reactions to BNT162B2, the patient was curious if she should take the second one, knowing how the patient's body. The patient waited for 30 minutes after the vaccine to make sure something didn't happen. The patient started to have lip swelling so she went back into the facility and waited a little longer, the swelling subsided on their own but then she started having shortness of breath through the evening, but not to the point to go to the emergency room. The patient felt like there was a lot of pressure on her chest, congestion and upset stomach. The main symptom was the heaviness in the chest. The outcome of congestion, lip swelling and upset stomach was recovering and the outcome of the rest of the events was unknown.
Tachycardia, redness to chest. Tachycardia lasted approx 8 minutes 224pm-232pm, redness to chest started approx 230pm, was flat blotchy area from bilateral lateral neck starting at lateral jaw line down over clavicle and meeting approx 4 inches into chest from base of neck. Appeared like a collar. did not extend to behind neck, back of arms or further down chest. No redness to abdomen or legs. Blotchy patches did move together and faded to a very light pink by 330pm. pt was monitored, assisted with deep breaths and due to the symptoms residing, no other medical intervention performed.
2 hrs after vaccine- headache 6 hours after vaccine- terrible headache 8 hours after vaccine- nausea and vomiting 24 hours after vaccine- hives& itching around stomach, legs
2days following vax pt exp pain in lt arm x2 wks. tender at inject site.
Low grade fever, nausea, headache  Prior medical diagnoses:  Hyperlipidemia dysmetabolic syndrome, diabetes, hypertension
Patient describes severe shoulder pain that began immediately after receiving AVA #4.  Shoulder was 0/10 pain prior to immunization.  Patient indicates that the injection was centered but high, adding that both he and the vaccinator were standing, but the vaccinator was much taller than him.  When first evaluated, patient's pain was 2/10 without movement and up to 8/10 with activity. Pain has increased over the past week because patient's spouse is away for work and he is caring for their 11mo by himself: pain is constant, now 5/10 at the lowest and 6-7/10 with activity. He describes the pain as 'grinding of bones.' Pain significantly disturbs sleep. Patient denies radiation or parasthesias but shoulder is weak compared to L. On exam there is no obvious deformity and pain not reproduced with superficial palpation. Patient is pos for Neer's sign but neg for cross arm.  Patient has been taking Mobic and Tylenol and doing HEP. He was referred for PT (start 15 MAY); had 4 session and received steroid injection on 23 MAY 2019. He has since been lost to followup.
This spontaneous report as received from a consumer via company representative refers to a male patient (reporter's nephew) of unknown age. Information regarding patient's medical history and drug reactions or allergies was not reported. On an unknown date (also reported as: "administered to him as a kid") the patient was vaccinated with MMR II (dose, route of administration, anatomical location, lot#, expiration date not reported). Concomitant medications were not reported. It was reported that the patient earlier this month (in approximately August 2014) visited a foreign country for about 10 days, returning on 16-AUG-2014. About a day after getting back (approximately on 17-AUG-2014), he began suffering from running nose which lasted for a couple days and was accompanied with a slight fever and cough. There was treatment given with D-COLD, aspirin, and acetaminophen for the events. The patient was also in the last stages of getting a tooth implant and had ibuprofen for the pain. On 18-AUG-2014 the patient submitted a blood sample for measles (rubeola) immunity test with the results of 155 U/ml of antibody, IgG serum. The outcome of the events was unknown. The relatedness between the therapy with MMR II and the events was not reported. Additional information has been requested.
felt very agitated; diarrhea; chills; blood pressure and it was like 170over 90; racing heart; pulse rate of 110; dizzy; This is a spontaneous report from a contactable non-healthcare professional. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3247), via an unspecified route of administration on the left arm on 17Mar2021 at 10:00 (at the age of 56-year-old), as a first single dose for COVID-19 immunisation. Medical history included bad back and knee. Concomitant medications included vit C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) all drugs started on an unknown date for unknown indications. The patient also reported that back was pulled out the week before and was in bed a few days and took a few unspecified muscle relaxers. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 00:30, after the shot, the patient experienced that night when sleeping woke up witha racing heart and felt very agitated. The blood pressure and pulse rate were measured and recorded as 170 over 90 with a pulse rate of 110. The patient got up because felt dizzy. The patient walked around kitchen for an hour until it passed. It happened again two days later. On 21Mar2021, three days after the shot, the patient experienced diarrhea and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events racing heart, felt very agitated, dizzy, diarrhea and chills were resolving at the time of the report.    No follow-up attempts are needed. No further information is expected.
Skin rash, urinary incontinence, alopecia (hair loss), frequency upon urination, weight gain.
Fever of 101.6; chills; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3248) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 41-years-old), as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 24Mar2021 at 02:00, the patient experienced fever of 101.6, chills, headache and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent body temperature and results was 101.6 (Unknown units). The patient did not received treatment for the reported events. The clinical outcome of the events fever, chills, headache and nausea were recovering at the time of this report.     No follow-up attempts are needed. No further information is expected.
Felt like vaccine hurt more than normal upon administration. Pinching (L) arm with movement continues. Pain varies from 3-6 on 1-10 scale. No redness/swelling or fever. Declines appointment in student health services.
stopped breathing 4 hrs p/immun taken to ER; CXR done; dx neurofibroma; has had 2 surgeries since; had been taking ATB for chest congestion x 6 days; had no fever;
itching; Rash at the injection site; rash at the injection site which started from the elbow spread to the shoulder, back of the neck; arm hurts; fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), INJECTION SITE RASH (Rash at the injection site), RASH (rash at the injection site which started from the elbow spread to the shoulder, back of the neck), PYREXIA (fever) and MYALGIA (arm hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching), INJECTION SITE RASH (Rash at the injection site), RASH (rash at the injection site which started from the elbow spread to the shoulder, back of the neck), PYREXIA (fever) and MYALGIA (arm hurts). At the time of the report, PRURITUS (itching), INJECTION SITE RASH (Rash at the injection site), RASH (rash at the injection site which started from the elbow spread to the shoulder, back of the neck) and MYALGIA (arm hurts) outcome was unknown and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 (High) 103.         Concomitant medications were not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
2nd day full body body aches, fever. Day 3 redness at injection site itchy warm to touch and painful.
Cluster headache behind right eye that turned into eye pain around/behind eye (not the eye itself)  Headache subsided with ibuprofen and Tylenol but pain around/behind eye persisted (currently on day 4, discomfort has subsided some but still noticeable)
Patient develops a big feverish lump/bump around the vaccine site with itchy, redness skin 7 days
diffuse  itchy body rash  on arms, legs, back, stomach.  Large areas of erythema, macular spots, raised blisters filled with clear fluid Seen 3/21-at Urgent Care-treated with abx for cellulitis of right calf;  Seen 3/23 by PCP and started on steroids with referral to dermatology.  Seen 3/24 by dermatology added topical steroid cream.  Seen 4/13 by dermatology for flare up after steroids weaned; steroids restarted.  Seen 4/20 rash not responding to steroid dose increased and dapsone added
covid; felt bad; was not feeling well; feeling weak; pain everywhere; sometimes he feel cold; somtimes he sweats; When he wakes up in the morning he feel good but later on he feel weak and drowsy; pain in hip and can barely walk; Dizzy; fever; feels so tired; headache; pain in hip; pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere) and FEELING COLD (sometimes he feel cold) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip) and ARTHRALGIA (pain in the shoulder). On 28-May-2021, the patient experienced COVID-19 (covid). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (felt bad), MALAISE (was not feeling well), ASTHENIA (feeling weak), PAIN (pain everywhere), FEELING COLD (sometimes he feel cold), HYPERHIDROSIS (somtimes he sweats), SOMNOLENCE (When he wakes up in the morning he feel good but later on he feel weak and drowsy), GAIT DISTURBANCE (pain in hip and can barely walk), DIZZINESS (Dizzy), PYREXIA (fever), FATIGUE (feels so tired), HEADACHE (headache), ARTHRALGIA (pain in hip), ARTHRALGIA (pain in the shoulder) and COVID-19 (covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28 May 2021 and new event ( COVID-19 ) was added. On 24-Jul-2021: Follow up information received on 24 Jul 2021 included no new information
Patient reports having severe upper thigh pain that started 4/20/2021. Patient stated that there have been no other symptoms at this time. Patient was advised to go to the emergency room immediately to get further evaluation. Patient verbalized agreement and stated that he would go to the nearest ER right away.
Pt devel t102(R) APAP given about 1/2 hr before immun; t105(R) @ about 5PM; started twitching arms & legs; lukewarm bath given; Temp up & down until 17MAY pt acting normally;
Ankle pain; Feels like ankle tendinitis; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Ep6955) via an unspecified route of administration in the left arm on 18Mar2021 at 12:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The medical history included asthma, endometriosis, IBS (irritable bowel syndrome) and essential tremors. The concomitant medications included vitamin b12 (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) for unknown indications. There were no known allergies of the patient. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since having the vaccine. On 18Mar2021 at 13:30, the patient experienced ankle pain which had felt like ankle tendinitis and had started hurting the day of vaccination. The patient also felt the pain when moving her foot or when walking for long periods of time. No therapeutic measures were taken as a result of ankle pain and tendinitis. The adverse events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of ankle pain and tendinitis was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a pharmacy intern concerning a female who on 9/12/06 the pt experienced nausea and vomiting. Unspecified medical attention was sought. At the time of this report, the outcome of the events was unk. Additional information has been requested.
Horrible headaches; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Jan2021(at the age of 53-years-old) , as a single dose for COVID-19 immunisation. The patient had known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 13Jan2021, the patient had horrible headaches and had not gone away. She went to doctor appointments and nothing has taken them away. Therapeutic measures were not taken as a result of the event.  The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event horrible headaches was not resolved at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Feb2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation.  The lot number for BNT162b2 was not provided and will be requested during follow up.
PATIENT CAME IN FOR SECOND DOSE OF SHINGLE VACCINES BUT WAS GIVEN COVID VACCINE INSTEAD
Pt c/o nausea and dizziness after the 3rd vaccine Varicella. Pt had syncopal episode lasting about 1 min. Placed in supine position. Respiratory status and V/S assessed and monitored.
patient broke out in measles type bumps that then turned into what sounded like hives on bicep and tricep in particular